West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) announced a quarterly dividend on Thursday, October 24th, Zacks reports. Investors of record on Wednesday, November 13th will be paid a dividend of 0.21 per share by the medical instruments supplier on Wednesday, November 20th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.25%. The ex-dividend date is Wednesday, November 13th. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20.
West Pharmaceutical Services has increased its dividend payment by an average of 5.8% per year over the last three years and has increased its dividend every year for the last 31 years. West Pharmaceutical Services has a dividend payout ratio of 10.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect West Pharmaceutical Services to earn $7.54 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 10.6%.
West Pharmaceutical Services Stock Performance
Shares of WST stock opened at $330.65 on Friday. The company has a market cap of $23.99 billion, a P/E ratio of 47.03, a PEG ratio of 10.21 and a beta of 1.01. The business has a 50 day moving average of $300.36 and a two-hundred day moving average of $322.86. West Pharmaceutical Services has a 52 week low of $265.00 and a 52 week high of $413.70. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03.
Insider Transactions at West Pharmaceutical Services
In related news, VP Charles Witherspoon sold 1,029 shares of West Pharmaceutical Services stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $300.00, for a total value of $308,700.00. Following the sale, the vice president now directly owns 1,478 shares in the company, valued at $443,400. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.53% of the company’s stock.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Further Reading
- Five stocks we like better than West Pharmaceutical Services
- ESG Stocks, What Investors Should Know
- The Downtrend in UPS Stock Isn’t Over Yet
- What is Put Option Volume?
- Maximize Portfolio Income with These 3 Dividend ETFs
- How to Invest in Biotech Stocks
- Talen Energy: A Nuclear Power Stock That Can Keep Winning
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.